The comparison of basal insulin therapy with average daily risk range (ADRR).
Phase of Trial: Phase II
Latest Information Update: 12 May 2016
At a glance
- Drugs Insulin degludec (Primary) ; Insulin glargine
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Adverse reactions; Pharmacodynamics
- 27 Nov 2015 New trial record